neoleukin.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Neoleukin Therapeutics | de novo Protein |
| Description | The Protein Design Revolution Begins Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 69.63.140.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
neoleukin.com Valuation
|
US$14,865,866
Last updated: 2023-04-27 23:09:47
neoleukin.com has Semrush global rank of 711,987. neoleukin.com has an estimated worth of US$ 14,865,866, based on its estimated Ads revenue. neoleukin.com receives approximately 1,715,293 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, neoleukin.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$14,865,866 |
| Daily Ads Revenue | US$13,723 |
| Monthly Ads Revenue | US$411,671 |
| Yearly Ads Revenue | US$4,940,042 |
| Daily Unique Visitors | 114,353 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| neoleukin.com. | A | 600 | IP: 69.63.140.80 |
| neoleukin.com. | NS | 3600 | NS Record: ns60.domaincontrol.com. |
| neoleukin.com. | NS | 3600 | NS Record: ns59.domaincontrol.com. |
| neoleukin.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
| neoleukin.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
| neoleukin.com. | TXT | 3600 | TXT Record: v=spf1 include:us._netblocks.mimecast.com include:spf.protection.outlook.com include:emailus.freshservice.com -all |
| neoleukin.com. | TXT | 3600 | TXT Record: ZOOM_verify_b0wdABxFTnS5oE4QpZz87Q |
| neoleukin.com. | TXT | 3600 | TXT Record: google-site-verification=fEoXLJtcnPWz-H06-IAb2Xlt_yQvcHSbk3ssvAcIIsI |
| neoleukin.com. | TXT | 3600 | TXT Record: apple-domain-verification=QRN4c05RlqSDiBz0 |
HtmlToTextCheckTime:2023-04-27 23:09:47
| The Protein Design Revolution Begins Here Neoleukin’s lead program, NL-201, is believed to be the world’s first computationally-designed de novo protein therapeutic. Our Approach Neoleukin is a pioneer in de novo protein development, leveraging computational methods to create new therapies. Learn More Team A committed team, dedicated to building an enduring company in service of the science, patients, employees, and the community. Learn More Programs A broad set of programs spanning multiple indications, including cancer and autoimmune diseases. Learn More Science Founded on seminal research, as featured in Nature , heralding a new era of custom protein design. Learn More About Mission Leadership Board of Directors Corporate Responsibility Contact Science De Novo Protein Design Neoleukin Platform Publications Collaborations & Partnerships Programs NL-201 Research News Press Releases Events In The News Media Contact Investors Press Releases Events & Presentations Financial and Filings |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 03:00:00 GMT Server: Apache Location: https://www.neoleukin.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 21 Oct 2021 03:00:00 GMT Server: Apache Vary: User-Agent,Accept-Encoding Last-Modified: Thu, 07 Oct 2021 21:07:34 GMT Cache-Control: max-age=30, s-maxage=30 Expires: Thu, 21 Oct 2021 03:00:30 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Content-Security-Policy-Report-Only: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self'; frame-src 'self' player.vimeo.com *.youtube.com www.google.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com www.googletagmanager.com maps.googleapis.com; img-src 'self' data: www.google-analytics.com maps.googleapis.com maps.gstatic.com www.googletagmanager.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
neoleukin.com Whois Information
Domain Name: NEOLEUKIN.COM Registry Domain ID: 2247676687_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-04-03T01:28:40Z Creation Date: 2018-04-04T00:49:10Z Registry Expiry Date: 2023-04-04T00:49:10Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T19:24:25Z <<< |